Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Revance Therapeutics, Inc. | 0 | reported | 06 Feb 2025 | tx 3−117,256 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Feb 2025 | OTHER | Revance Therapeutics, Inc. | 107,942 | — | |
| 04 Feb 2025 | TENDER | Revance Therapeutics, Inc. | 6,922 | 3.65 USD | |
| 16 Apr 2024 | SALE | Revance Therapeutics, Inc. | 2,392 | 3.80 USD |